SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-23-096910
Filing Date
2023-12-19
Accepted
2023-12-19 16:01:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea190271-13da1oudom_bimi.htm SC 13D/A 42630
  Complete submission text file 0001213900-23-096910.txt   44318
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Subject) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82052 | Film No.: 231497198
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)

Mailing Address 7700 IRVINE CENTRE DRIVE SUITE 800 IRVINE CA 92618
Business Address
Oudom Fnu (Filed by) CIK: 0001858293 (see all company filings)

Type: SC 13D/A